Work

Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR -mutant lung adenocarcinoma

Year: 2017

Type: article

Source: Biochemical and Biophysical Research Communications

DOI: 10.1016/j.bbrc.2017.04.102

Authors: Miki Yamaguchi, Sachie Hirai, Toshiyuki Sumi, Yusuke Tanaka, Makoto Tada, Yukari Nishii, Tadashi Hasegawa, Hiroaki Uchida, Gen Yamada, Atsushi Watanabe, Hiroki Takahashi, Yuji Sakuma

Institutions: Sapporo Medical University, Research Institute for Frontier Medicine, Sapporo Medical University, Institute of Medical Science, The University of Tokyo, The University of Tokyo

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: Japan Society for the Promotion of Science

Awards: Integrative analyses of lung adenocarcinomas that have undergone epithelial to mesenchymal transition (EMT) and those that retain an epithelial phenotype, Generation of immunotoxins with super-targeting mAb in the EGFR-mutant lung adenocarcinoma

OpenAlex ID: W2607216367

FWCI: 0.617

Cites: 20

Cited by: 21

Related to: 10